Erratum: Revascularization of ischemic skeletal muscle by estrogen-related receptor-γ (Circulation Research (2012) 110 (1087-1096) DOI: 10.1161/CIRCRESAHA.112.266478);Revascularization of ischemic skeletal muscle by estrogen-related receptor-γ

Circulation Research

Volumn 110, Issue 8, 2012, Pages 1087-1096

  Matsakas, Antonios ^a   Yadav, Vikas ^a   Lorca, Sabina ^a   Evans, Ronald M ^b,c   Narkar, Vihang A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

estrogen related receptors; hypoxia; ischemia; neoangiogenesis; skeletal muscle

Indexed keywords

ANGIOGENIC FACTOR; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HINDLIMB; IMMUNOHISTOLOGY; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MICROANGIOGRAPHY; MOUSE; MUSCLE ISCHEMIA; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVASCULARIZATION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; WILD TYPE;

EID: 84859891695     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0b013e31827806cf     Document Type: Erratum

References (51)

1. Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg. 2010;51:230-241.
2. Chi YW, Osinbowale O, Milani R. Genetic association studies in peripheral arterial disease. J La State Med Soc. 2011;163:30-39.
3. Baumgartner I, Schainfeld R, Graziani L. Management of peripheral vascular disease. Annu Rev Med. 2005;56:249-272. (Pubitemid 40299783)
4. Conrad MF, Crawford RS, Hackney LA, Paruchuri V, Abularrage CJ, Patel VI, Lamuraglia GM, Cambria RP. Endovascular management of patients with critical limb ischemia. J Vasc Surg. 2011;53:1020-1025.
5. Cao Y, Hong A, Schulten H, Post MJ. Update on therapeutic neovascularization. Cardiovasc Res. 2005;65:639-648. (Pubitemid 40138984)
6. van Weel V, van Tongeren RB, van Hinsbergh VW, van Bockel JH, Quax PH. Vascular growth in ischemic limbs: A review of mechanisms and possible therapeutic stimulation. Ann Vasc Surg. 2008;22:582-597.
7. Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov. 2003;2:863-871. (Pubitemid 37407792)
8. Lekas M, Lekas P, Latter DA, Kutryk MB, Stewart DJ. Growth factorinduced therapeutic neovascularization for ischaemic vascular disease: Time for a re-evaluation? Curr Opin Cardiol. 2006;21:376-384. (Pubitemid 44315071)
9. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298-307.
10. Annex BH, Torgan CE, Lin P, Taylor DA, Thompson MA, Peters KG, Kraus WE. Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol. 1998; 274:H860-H867.
11. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992;72:369-417.
12. Ripoll E, Sillau AH, Banchero N. Changes in the capillarity of skeletal muscle in the growing rat. Pflugers Arch. 1979;380:153-158. (Pubitemid 9218652)
13. Prior BM, Lloyd PG, Ren J, Li H, Yang HT, Laughlin MH, Terjung RL. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol Heart Circ Physiol. 2004;287:H2434-H2447. (Pubitemid 39557112)
14. Yang HT, Prior BM, Lloyd PG, Taylor JC, Li Z, Laughlin MH, Terjung RL. Training-induced vascular adaptations to ischemic muscle. J Physiol Pharmacol. 2008;59(Suppl 7):57-70.
15. Cherwek DH, Hopkins MB, Thompson MJ, Annex BH, Taylor DA. Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia. Am J Physiol Heart Circ Physiol. 2000;279: H932-H938.
16. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, Spiegelman BM. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451: 1008-1012. (Pubitemid 351301733)
17. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008;134:405-415.
18. Gaudel C, Schwartz C, Giordano C, Abumrad NA, Grimaldi PA. Pharmacological activation of PPARbeta promotes rapid and calcineurindependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am J Physiol Endocrinol Metab. 2008;295:E297-E304.
19. Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev. 2008;29:677-696.
20. Narkar VA, Fan W, Downes M, Yu RT, Jonker JW, Alaynick WA, Banayo E, Karunasiri MS, Lorca S, Evans RM. Exercise and PGC-1alpha-independent synchronization of type i muscle metabolism and vasculature by ERRgamma. Cell Metab. 2011;13:283-293.
21. Rangwala SM, Wang X, Calvo JA, Lindsley L, Zhang Y, Deyneko G, Beaulieu V, Gao J, Turner G, Markovits J. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. J Biol Chem. 2010;285:22619-22629.
22. Limbourg A, Korff T, Napp LC, Schaper W, Drexler H, Limbourg FP. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc. 2009;4:1737-1746.
23. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324:1710-1713.
24. Hershey JC, Corcoran HA, Baskin EP, Gilberto DB, Mao X, Thomas KA, Cook JJ. Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction. Cardiovasc Res. 2003;59:997-1005. (Pubitemid 38366256)
25. Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ, Lindner JR. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res. 2007;101:295-303. (Pubitemid 47344079)
26. Uniewicz KA, Cross MJ, Fernig DG. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. J Biol Chem. 2011;286: 12-23.
27. Dehne N, Kerkweg U, Otto T, Fandrey J. The HIF-1 response to simulated ischemia in mouse skeletal muscle cells neither enhances glycolysis nor prevents myotube cell death. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1693-R1701. (Pubitemid 47535788)
28. Barak S, Stopka CB, Archer Martinez C, Carmeli E. Benefits of lowintensity pain-free treadmill exercise on functional capacity of individuals presenting with intermittent claudication due to peripheral arterial disease. Angiology. 2009;60:477-486.
29. Pena KE, Stopka CB, Barak S, Gertner HR Jr, Carmeli E. Effects of low-intensity exercise on patients with peripheral artery disease. Phys Sportsmed. 2009;37:106-110.
30. Waters RE, Rotevatn S, Li P, Annex BH, Yan Z. Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am J Physiol Cell Physiol. 2004;287:C1342-C1348. (Pubitemid 39382893)
31. Rowe GC, Jang C, Patten IS, Arany Z. PGC-1beta regulates angiogenesis in skeletal muscle. Am J Physiol Endocrinol Metab. 2011;301: E155-E163.
32. Hentschke M, Susens U, Borgmeyer U. PGC-1 and PERC, coactivators of the estrogen receptor-related receptor gamma. Biochem Biophys Res Commun. 2002;299:872-879. (Pubitemid 36034567)
33. Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and-gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem. 2002;277:40265-40274. (Pubitemid 35215598)
34. Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, Fritah A, Mobberley M, Ryder TA, Rowlerson A, Scott J, Poutanen M, White R, Parker M. The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab. 2007;6:236-245. (Pubitemid 47324141)
35. Castet A, Herledan A, Bonnet S, Jalaguier S, Vanacker JM, Cavailles V. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol. 2006;20:1035-1047.
36. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, Walsh K, Sessa WC. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest. 2005;115:2119-2127. (Pubitemid 41134153)
37. Ohashi K, Ouchi N, Higuchi A, Shaw RJ, Walsh K. LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis. J Biol Chem. 2010;285:22291-22298.
38. Ohashi K, Ouchi N, Sato K, Higuchi A, Ishikawa TO, Herschman HR, Kihara S, Walsh K. Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism. Mol Cell Biol. 2009;29:3487-3499.
39. Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, Izumiya Y, Walsh K. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem. 2008;283:32802-32811.
40. Al Haj Zen A, Oikawa A, Bazan-Peregrino M, Meloni M, Emanueli C, Madeddu P. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circ Res. 2010;107:283-293.
41. Semenza GL. Hydroxylation of hif-1: Oxygen sensing at the molecular level. Physiology (Bethesda). 2004;19:176-182. (Pubitemid 39481932)
42. Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA. 2008;105:7821-7826. (Pubitemid 351872722)
43. Bento CF, Pereira P. Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes. Diabetologia. 2011; 54:1946-1956.
44. Semenza GL. Regulation of vascularization by hypoxia-inducible factor. Ann N Y Acad Sci. 2009;1177:2-8.
45. Sneider EB, Nowicki PT, Messina LM. Regenerative medicine in the treatment of peripheral arterial disease. J Cell Biochem. 2009;108: 753-761.
46. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841-850. (Pubitemid 26006526)
47. Chao EY, Collins JL, Gaillard S, Miller AB, Wang L, Orband-Miller LA, Nolte RT, McDonnell DP, Willson TM, Zuercher WJ. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. Bioorg Med Chem Lett. 2006;16:821-824. (Pubitemid 43059830)
48. Coward P, Lee D, Hull MV, Lehmann JM. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc Natl Acad Sci USA. 2001;98:8880-8884. (Pubitemid 32678121)
49. Zuercher WJ, Gaillard S, Orband-Miller LA, Chao EY, Shearer BG, Jones DG, Miller AB, Collins JL, McDonnell DP, Willson TM. Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgamma. J Med Chem. 2005;48:3107-3109. (Pubitemid 40628027)
50. Heard DJ, Norby PL, Holloway J, Vissing H. Human ERRrgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: Tissue-specific isoforms are expressed during development and in the adult. Mol Endocrinol. 2000;14:382-392. (Pubitemid 32260530)
51. Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem. 1999;274:22618-22626.